13F HOLDINGS REPORT
SUPERSTRING CAPITAL MANAGEMENT LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001931118-26-000003
Total Value
$186.8M
Positions
45
Other Managers
0
Confidential Omitted
No
Holdings (45)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CIDARA THERAPEUTICS INC | 171757206 | 85,098 | $18.8M | 10.06% |
| 2 | TERNS PHARMACEUTICALS INC | TERN | 443,777 | $17.9M | 9.60% |
| 3 | UROGEN PHARMA LTD | URGN | 718,354 | $16.8M | 9.01% |
| 4 | COGENT BIOSCIENCES INC | COGT | 366,238 | $13.0M | 6.96% |
| 5 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 525,592 | $8.1M | 4.33% |
| 6 | SIONNA THERAPEUTICS INC | SION | 180,593 | $7.4M | 3.98% |
| 7 | IMMUNOVANT INC | IMVT | 288,677 | $7.3M | 3.93% |
| 8 | AXSOME THERAPEUTICS INC | AXSM | 37,433 | $6.8M | 3.66% |
| 9 | SAVARA INC | SVRA | 995,353 | $6.0M | 3.21% |
| 10 | MIND MEDICINE MINDMED INC | 60255C885 | 425,202 | $5.7M | 3.05% |
| 11 | TAYSHA GENE THERAPIES INC | TSHA | 980,768 | $5.4M | 2.89% |
| 12 | OCULAR THERAPEUTIX INC | OCUL | 418,080 | $5.1M | 2.72% |
| 13 | AMICUS THERAPEUTICS INC | FOLD | 352,896 | $5.0M | 2.69% |
| 14 | CABALETTA BIO INC | CABA | 2,253,550 | $4.9M | 2.64% |
| 15 | UNITED THERAPEUTICS CORP DEL | UTHR | 9,451 | $4.6M | 2.47% |
| 16 | REVOLUTION MEDICINES INC | RVMDW | 54,879 | $4.4M | 2.34% |
| 17 | BELITE BIO INC | BLTE | 24,703 | $4.0M | 2.12% |
| 18 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 47,278 | $3.7M | 1.98% |
| 19 | ZAI LAB LTD | ZLAB | 196,853 | $3.5M | 1.86% |
| 20 | ZENAS BIOPHARMA INC | ZBIO | 83,353 | $3.0M | 1.62% |
| 21 | QUINCE THERAPEUTICS INC | QNCX | 858,711 | $2.9M | 1.54% |
| 22 | AVALO THERAPEUTICS INC | AVTX | 153,313 | $2.8M | 1.49% |
| 23 | CAPRICOR THERAPEUTICS INC | CAPR | 96,334 | $2.8M | 1.49% |
| 24 | PALVELLA THERAPEUTICS INC NE | PVLA | 25,469 | $2.7M | 1.43% |
| 25 | CELLDEX THERAPEUTICS INC NEW | CLDX | 88,308 | $2.4M | 1.28% |
| 26 | ASSEMBLY BIOSCIENCES INC | ASMB | 65,273 | $2.2M | 1.19% |
| 27 | ORIC PHARMACEUTICALS INC | ORIC | 255,370 | $2.1M | 1.12% |
| 28 | PROTARA THERAPEUTICS INC | TARA | 360,000 | $1.9M | 1.03% |
| 29 | TREVI THERAPEUTICS INC | TRVI | 148,292 | $1.9M | 0.99% |
| 30 | TYRA BIOSCIENCES INC | TYRA | 58,677 | $1.5M | 0.83% |
| 31 | TRAVERE THERAPEUTICS INC | TVTX | 38,022 | $1.5M | 0.78% |
| 32 | VIRIDIAN THERAPEUTICS INC | VRDN | 43,230 | $1.3M | 0.72% |
| 33 | REZOLUTE INC | RZLT | 513,765 | $1.2M | 0.65% |
| 34 | DIANTHUS THERAPEUTICS INC | DNTH | 26,249 | $1.1M | 0.58% |
| 35 | SPRUCE BIOSCIENCES INC | SPRB | 12,137 | $1.1M | 0.57% |
| 36 | AARDVARK THERAPEUTICS INC | AARD | 69,496 | $912,135 | 0.49% |
| 37 | GENMAB A/S | GNMSF | 29,162 | $898,190 | 0.48% |
| 38 | PALISADE BIO INC | PALI | 367,103 | $862,692 | 0.46% |
| 39 | FULCRUM THERAPEUTICS INC | FULC | 72,060 | $814,999 | 0.44% |
| 40 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 31,738 | $729,974 | 0.39% |
| 41 | PALATIN TECHNOLOGIES INC | PTN | 33,971 | $522,474 | 0.28% |
| 42 | INVENTIVA SA | IVEVF | 100,000 | $465,000 | 0.25% |
| 43 | CENTURY THERAPEUTICS INC | IPSC | 462,963 | $460,556 | 0.25% |
| 44 | BIOMEA FUSION INC | BMEA | 250,000 | $310,000 | 0.17% |
| 45 | ENTERA BIO LTD | ENTX | 17,142 | $33,255 | 0.02% |